Clinical Trial Update: PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers [Phase 4]

View source ↗

Summary

Phase 4 trial comparing proton pump inhibitors to H2 receptor antagonists in Helicobacter pylori–negative idiopathic bleeding ulcers; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Peptic Ulcer | Phase 4 | Status: COMPLETED